(Q48828685)

15 February 2018

title

Pravastatin for thioacetamide-induced hepatic failure and encephalopathy. (English)

1 reference

15 February 2018

main subject

thioacetamide

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

Hui-Chun Huang

1

1 reference

15 February 2018

Ching-Chih Chang

2

1 reference

15 February 2018

Sun-Sang Wang

3

1 reference

15 February 2018

Cho-Yu Chan

4

1 reference

15 February 2018

Fa-Yauh Lee

5

1 reference

15 February 2018

Chiao-Lin Chuang

6

1 reference

15 February 2018

I-Fan Hsin

7

1 reference

15 February 2018

Tzu-Hua Teng

8

1 reference

15 February 2018

Han-Chieh Lin

9

1 reference

15 February 2018

Shou-Dong Lee

10

1 reference

15 February 2018

publication date

12 July 2011

1 reference

15 February 2018

European Journal of Clinical Investigation

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

15 February 2018

volume

42

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

139-145

1 reference

15 February 2018

Current theories on the pathogenesis of hepatic encephalopathy

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Nitric oxide and prostaglandin E2 formation parallels blood-brain barrier disruption in an experimental rat model of bacterial meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Nitric oxide in hepatic encephalopathy and hyperammonemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Detrimental effects of nitric oxide inhibition on hepatic encephalopathy in rats with thioacetamide-induced fulminant hepatic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Lack of detrimental effects of nitric oxide inhibition in bile duct-ligated rats with hepatic encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

The impact of time after portacaval shunt in the rat on behavior, brain serotonin, and brain and muscle histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Endothelial nitric oxide synthase-dependent cerebral blood flow augmentation by L-arginine after chronic statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Safety and statin therapy: reconsidering the risks and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Pravastatin inhibits arrhythmias induced by coronary artery ischemia in anesthetized rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

Dose translation from animal to human studies revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2011.02566.X

10.1111/J.1365-2362.2011.02566.X

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

1 reference

15 February 2018